The role of testing in the fight against COVID-19: Current happenings in Africa and the way forward.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 14 04 2020
revised: 23 06 2020
accepted: 25 06 2020
pubmed: 4 7 2020
medline: 22 9 2020
entrez: 4 7 2020
Statut: ppublish

Résumé

The dramatic increase in suspected COVID-19 cases in Africa has placed an enormous burden on public and private clinical facilities. To date, the most commonly used method for identifying and confirming the virus is the laboratory-based reverse transcription-polymerase chain reaction (RT-PCR) test. Unfortunately, testing capacities have been limited in many parts of Africa because of inadequate test kits, which have restricted scaling up beyond the few public health laboratories at designated locations. In this mini-review, we present Africa's preparedness and readiness for testing, why testing is crucial, the need to immediately strengthen existing facilities, and what it involves as part of combined approaches for managing the COVID-19 crisis. The review highlights the urgent need for speedy expansion and distribution of several laboratory testing platforms, including real-time PCR and serological assays to both public health facilities and fully accredited private clinical laboratories.

Identifiants

pubmed: 32619756
pii: S1201-9712(20)30525-7
doi: 10.1016/j.ijid.2020.06.089
pmc: PMC7326437
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-240

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
Clin Chem. 2020 May 1;66(5):664-666
pubmed: 32077933
Swiss Med Wkly. 2020 Mar 19;150:w20225
pubmed: 32191813
J Med Virol. 2020 Jun;92(6):538-539
pubmed: 32096564
JAMA. 2020 Mar 17;323(11):1039-1040
pubmed: 32022836

Auteurs

Abdul-Aziz Seidu (AA)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, Australia. Electronic address: abdul-aziz.seidu@stu.ucc.edu.gh.

John Elvis Hagan (JE)

Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana; Neurocognition and Action-Biomechanics-Research Group, Faculty of Psychology and Sport Sciences, Bielefeld University, Bielefeld, Germany. Electronic address: elvis.hagan@ucc.edu.gh.

Edward Kwabena Ameyaw (EK)

The Australian Centre for Public and Population Health Research [ACPPHR], Faculty of Health, University of Technology Sydney, Australia. Electronic address: edmeyaw19@gmail.com.

Bright Opoku Ahinkorah (BO)

The Australian Centre for Public and Population Health Research [ACPPHR], Faculty of Health, University of Technology Sydney, Australia. Electronic address: brightahinkorah@gmail.com.

Thomas Schack (T)

Neurocognition and Action-Biomechanics-Research Group, Faculty of Psychology and Sport Sciences, Bielefeld University, Bielefeld, Germany. Electronic address: thomas.schack@uni-bielefeld.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH